|
|
Volumn 80, Issue 11, 1999, Pages 1767-1769
|
|
Toxicity and feasibility of adjuvant high-dose interferon alpha-2b in patients with melanoma in clinical oncologic practice
a
|
|
Author keywords
Adjuvant treatment; Immunotherapy; Interferon alpha; Melanoma; Toxicity
|
|
Indexed keywords
ALPHA2B INTERFERON;
ALOPECIA;
ARTICLE;
ASTHENIA;
CANCER IMMUNOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DIARRHEA;
FEVER;
FOLLOW UP;
HEADACHE;
HUMAN;
INFECTION;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER TOXICITY;
MELANOMA;
MENTAL DISEASE;
MULTICENTER STUDY;
MYALGIA;
NAUSEA;
NEUTROPENIA;
PRIORITY JOURNAL;
SIDE EFFECT;
SUBCUTANEOUS DRUG ADMINISTRATION;
THROMBOCYTOPENIA;
VOMITING;
ANTINEOPLASTIC AGENTS;
CHEMOTHERAPY, ADJUVANT;
DRUG ADMINISTRATION SCHEDULE;
FEASIBILITY STUDIES;
FOLLOW-UP STUDIES;
HUMANS;
INTERFERON ALFA-2B;
LYMPH NODE EXCISION;
LYMPHATIC METASTASIS;
MELANOMA;
PATIENT SELECTION;
PROSPECTIVE STUDIES;
SKIN NEOPLASMS;
TIME FACTORS;
|
|
EID: 0032767684
PISSN: 00070920
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.bjc.6690595 Document Type: Article |
|
Times cited : (25)
|
|
References (2)
|
